Quick Answer
INTERPACE BIOSCIENCES, INC. reported Diluted EPS of $0.89 per share for fiscal year 2025.
INTERPACE BIOSCIENCES, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.89 | +122.5% |
| 2024 | $0.40 | -11.1% |
| 2023 | $0.45 | +108.7% |
| 2022 | -$5.18 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.03 | -92.1% | +121.4% |
| June 30, 2025 | -$0.14 | -125.5% | -333.3% |
| March 31, 2025 | $0.06 | -62.5% | -84.2% |
| September 30, 2024 | $0.38 | +371.4% | -30.9% |
| June 30, 2024 | $0.55 | +1275.0% | +243.8% |
| March 31, 2024 | $0.16 | +100.0% | +214.3% |
| September 30, 2023 | -$0.14 | +95.8% | -450.0% |
| June 30, 2023 | $0.04 | +104.3% | -50.0% |
- INTERPACE BIOSCIENCES, INC. showed an increase of +122.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, INTERPACE BIOSCIENCES, INC.’s diluted eps has grown by 117.2% (from $5.18 per share (loss) to $0.89 per share).
- The most recent figure is from INTERPACE BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: